Amolyt Pharma
France-based company specialized in developing therapeutic peptides for rare endocrine and related diseases
Lyon, Franceamolytpharma.com ↗
Total raised
€129M
€129,159,062
Funding rounds
1
Investors
16
distinct backers
Active since
2023-01
latest 2023-01
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood37
base rate 50% for Series C
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-01-09 | Series C | €129M | Andera Partners,ATEM,Credit Agricole Creation,CTI Life Sciences,EQT Life Sciences,Innobio 2+10 more | View deal → |
Investors
16Related news
- French pharma Amolyt nets €130 million series C co-led by Sofinnova Partnerstech.eu · 2023-01
- Amolyt Pharma Raises $138M in Series C Financingfinsmes.com · 2023-01
Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software